Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sounds news, not just sound bites since 2011.
Today our host Lori La Bey will be talking with the Chief Medical Officer at Cortexyme, Dr. Michael Detke. Cortexyme is a bio tech company that is developing therapies targeting bacteria P. gingivalis, commonly associated with gum disease, that can infect the brain and cause Alzheimer’s disease. Dr. Detke is a boar...
Alzheimer's Speaks Radio - Shifting dementia care from crisis to comfort around the world one episode at a time by raising all voices and delivering sounds news, not just sound bites since 2011.
Today our host Lori La Bey will be talking with the Chief Medical Officer at Cortexyme, Dr. Michael Detke. Cortexyme is a bio tech company that is developing therapies targeting bacteria P. gingivalis, commonly associated with gum disease, that can infect the brain and cause Alzheimer’s disease. Dr. Detke is a board-certified psychiatrist and has been involved in clinical drug research and development for more than 20 years, having trained in psychiatry at Harvard Medical School.
To learn more about the GAIN Alzheimer's Trial and locations near you.
Contact Lori La Bey with questions or branding needs
Website: www.AlzheimersSpeaks.com Email: Lori@AlzheimersSpeaks.com Phone: 651-748-4714
Additional Resources Dementia Chats Projects & Initiatives Speaking/Training/Consulting
Support this Show: https://alzheimersspeaks.com/donate-now/
See omnystudio.com/listener for privacy information.
View more